Correlation Between Predictive Oncology and Femasys

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Predictive Oncology and Femasys at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Predictive Oncology and Femasys into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Predictive Oncology and Femasys, you can compare the effects of market volatilities on Predictive Oncology and Femasys and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Predictive Oncology with a short position of Femasys. Check out your portfolio center. Please also check ongoing floating volatility patterns of Predictive Oncology and Femasys.

Diversification Opportunities for Predictive Oncology and Femasys

-0.1
  Correlation Coefficient

Good diversification

The 3 months correlation between Predictive and Femasys is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Predictive Oncology and Femasys in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Femasys and Predictive Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Predictive Oncology are associated (or correlated) with Femasys. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Femasys has no effect on the direction of Predictive Oncology i.e., Predictive Oncology and Femasys go up and down completely randomly.

Pair Corralation between Predictive Oncology and Femasys

Given the investment horizon of 90 days Predictive Oncology is expected to under-perform the Femasys. In addition to that, Predictive Oncology is 1.56 times more volatile than Femasys. It trades about -0.02 of its total potential returns per unit of risk. Femasys is currently generating about 0.0 per unit of volatility. If you would invest  109.00  in Femasys on August 31, 2024 and sell it today you would lose (5.00) from holding Femasys or give up 4.59% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Predictive Oncology  vs.  Femasys

 Performance 
       Timeline  
Predictive Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Predictive Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest conflicting performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.
Femasys 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Femasys has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong primary indicators, Femasys is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Predictive Oncology and Femasys Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Predictive Oncology and Femasys

The main advantage of trading using opposite Predictive Oncology and Femasys positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Predictive Oncology position performs unexpectedly, Femasys can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Femasys will offset losses from the drop in Femasys' long position.
The idea behind Predictive Oncology and Femasys pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies